32,801
Total Claims
$1.2M
Drug Cost
1,856
Beneficiaries
$670
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
-56%
Cost per patient vs peers
$670 vs $1,524 avg
Brand vs Generic
100% generic
Brand: 0 claims · $0
Generic: 29,842 claims · $418K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 354 | $220K |
| Ticagrelor | 330 | $162K |
| Rivaroxaban | 167 | $108K |
| Dapagliflozin Propanediol | 93 | $56K |
| Sitagliptin Phos/Metformin Hcl | 84 | $50K |
| Empagliflozin | 72 | $49K |
| Levothyroxine Sodium | 581 | $35K |
| Flecainide Acetate | 1,009 | $34K |
| Sacubitril/Valsartan | 48 | $28K |
| Candesartan Cilexetil | 351 | $24K |
| Bisoprolol/Hydrochlorothiazide | 908 | $21K |
| Amlodipine Bes/Olmesartan Med | 422 | $21K |
| Ranolazine | 182 | $17K |
| Nitroglycerin | 1,241 | $17K |
| Metoprolol Succinate | 1,457 | $16K |
Prescribing Profile
110
Unique Drugs
$477K
Patient Profile
73
Avg Age
57%
Female
1.98
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data